7 August 2025
Sidley Advises Permira and CNS Pharmaceutical Leader Neuraxpharm on €925 Million Refinancing
Advising firms
Deal team
9 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Jay Sadanandan Lead | Sidley | Partner | Global Finance | Not stated |
| Ben Wright Lead | Sidley | Partner | Global Finance | Not stated |
| Carry Chen | Sidley | Counsel | Global Finance | Not stated |
| Phil Cerny | Sidley | Senior associate | Global Finance | Not stated |
| Markus Feil | Sidley | Partner | Global Finance | Not stated |
| Christian Axhausen | Sidley | Senior associate | Global Finance | Not stated |
| Alissia Opitz | Sidley | Associate | Global Finance | Not stated |
| Steve Quinn | Sidley | Partner | Tax | Not stated |
| Ryan Power | Sidley | Associate | Tax | Not stated |
6 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- EUR 925m (€925 million)
- What the figure measures
- Facility amount
- Client
- Not stated
- Counterparties
- Permira (Sponsor)
Neuraxpharm (Borrower)